Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence [NA]

View source ↗

Summary

A multi-center trial evaluating Botox (onabotulinumtoxinA) for severe urge urinary incontinence has completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Rochester | Conditions: Urinary Incontinence | NA | Status: COMPLETED | Results posted: 2017-07-11